Propiedad y actividad de insiders de Lifecore Biomedical, Inc. (LFCR): operaciones de insiders, transacciones del Senado y la Cámara de EE. UU. y acciones en circulación. Sigue cómo operan la acción los directivos y los políticos.
Precio
| Precio | $4.16 |
| Capitalización | $156M |
| Bolsa | NASDAQ |
| País | US |
Balance (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Caja y Equivalentes | $5.4M | $2.9M | $1.1M | $360000 | $1.2M | $991000 | $19.1M | $8.5M | $8.3M | $17.5M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cuentas por Cobrar | $45.9M | $53.9M | $69.6M | $76.2M | $41.4M | $38.3M | $29.0M | $31.2M | $43.7M | $33.8M |
| Inventario | $25.3M | $31.8M | $54.1M | $66.3M | $63.1M | $36.0M | $40.8M | $40.0M | $32.3M | $29.1M |
| Activos Corrientes | $81.3M | $97.1M | $133.0M | $157.1M | $148.3M | $116.7M | $93.9M | $81.0M | $85.7M | $82.3M |
| Inmovilizado Material | $133.2M | $159.6M | $200.0M | $217.7M | $137.4M | $124.2M | $138.7M | $149.2M | $129.0M | $127.3M |
| Fondo de Comercio | $54.8M | $54.5M | $76.7M | $69.4M | $33.9M | $13.9M | $13.9M | $13.9M | $13.9M | $13.9M |
| Activos Intangibles | $22.8M | $21.8M | $45.2M | $38.1M | $25.6M | $4.2M | $4.2M | $4.2M | $4.2M | 0 |
| Activos Totales | $358.0M | $404.7M | $519.1M | $541.3M | $502.9M | $274.7M | $253.5M | $254.0M | $239.3M | $232.2M |
| Cuentas por Pagar | $24.5M | $34.7M | $54.0M | $51.6M | $16.3M | $13.0M | $22.1M | $16.3M | $8.2M | $5.8M |
| Deuda a Corto | $7.9M | $31.9M | $61.8M | $89.0M | $29.0M | $138.2M | $580000 | $943000 | $3.4M | $773000 |
| Pasivos Corrientes | $51.5M | $88.4M | $137.1M | $164.4M | $101.9M | $176.6M | $39.3M | $38.9M | $30.2M | $23.6M |
| Deuda a Largo | $42.3M | $37.4M | $87.7M | $101.4M | $164.9M | $97.6M | $101.1M | $123.7M | $127.0M | $135.6M |
| Pasivos Totales | $129.9M | $152.1M | $248.9M | $310.3M | $300.1M | $186.9M | $257.8M | $242.6M | $238.0M | $246.4M |
| Reservas | $84.5M | $109.3M | $109.7M | $71.2M | $38.6M | -$79.0M | -$178.5M | -$166.5M | -$205.2M | -$223.2M |
| Patrimonio Neto | $226.6M | $252.6M | $270.1M | $231.0M | $202.8M | $87.8M | -$4.2M | $11.3M | $1.3M | -$14.2M |
| Deuda Total | $54.0M | $72.9M | $152.5M | $221.1M | $215.9M | $247.8M | $112.6M | $133.6M | $130.8M | $142.6M |
| Deuda Neta | $48.6M | $70.0M | $151.4M | $220.8M | $214.7M | $246.8M | $93.5M | $125.1M | $122.6M | $125.1M |
| Capital Circulante | $29.8M | $8.7M | -$4.0M | -$7.3M | $46.4M | -$59.9M | $54.6M | $42.2M | $55.5M | $58.7M |
Salud financiera
| Deuda / Patrimonio | 9.64 |
| Ratio corriente | 3.87 |
Rentabilidad
| Rentabilidad sobre capital | -376.95% |
| Rentabilidad sobre capital invertido | -1.25% |
| Rentabilidad sobre activos | -16.25% |
| Margen bruto | 29.68% |
| Margen operativo | -2.12% |
| Margen neto | -30.40% |
Empresas relacionadas: ACB · ACHV · BIOA · CGC · CVRX · IMMP · OMI
Explorar sector: Healthcare · Drug Manufacturers - Specialty & Generic
Más secciones de LFCR: Resumen · Financieros · Valoración · Estadísticas · Estimaciones · Técnico · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones